```html

X‑Ray Induced Skin Burns

Overview

X‑ray induced skin burns, also called radiation dermatitis or radiation‑induced skin injury, are acute or chronic damage to the skin that results from exposure to ionising radiation used in diagnostic or therapeutic X‑ray procedures. The injury ranges from mild erythema (redness) to full‑thickness ulceration comparable to a thermal burn.

Although widely discussed in the context of high‑dose radiation therapy for cancer, skin burns can also arise from repeated or prolonged use of diagnostic X‑ray equipment (e.g., fluoroscopy, interventional radiology, computed tomography) when radiation safety protocols are not strictly followed.

Who is affected? Anyone undergoing repeated imaging, especially if the beam is focused on a small anatomical area, is at risk. Health‑care workers who operate fluoroscopy units without proper shielding are also susceptible. The incidence is relatively low—estimates suggest 0.5–2 % of patients receiving high‑dose fluoroscopic procedures develop clinically significant skin injury (NIH, 2018), while occupational burns are rare (CDC, 2022).

Symptoms

Skin reactions develop in a predictable sequence that correlates with the absorbed radiation dose (measured in gray, Gy). The following list covers the full spectrum of manifestations:

• Erythema (Redness): Appears 12–24 hours after exposure; looks like a sunburn.
• Dry desquamation (Peeling): 2–4 weeks post‑exposure; fine, dry scales.
• Moist desquamation: 3–6 weeks; weeping, painful skin loss.
• Edema (Swelling): May accompany erythema, especially in high‑dose (> 10 Gy) exposures.
• Hyperpigmentation or hypopigmentation: Darkening or lightening of the skin lasting months to years.
• Ulceration: Full‑thickness skin loss, possibly exposing underlying tissue; can occur > 20 Gy.
• Telangiectasia: Small, visible blood vessels appearing months to years after injury.
• Fibrosis (Hardening of skin): Chronic thickening and loss of flexibility.
• Pain or burning sensation: Varies from mild discomfort to severe, throbbing pain.
• Pruritus (Itching): Common during the healing phase.

Causes and Risk Factors

Radiation burns result when ionising photons deposit enough energy in the epidermis and dermis to break molecular bonds, generate free radicals, and damage DNA. The risk is influenced by several factors:

Procedural causes

• High‑dose fluoroscopy: Interventional cardiology, neuroradiology, and pain‑management procedures often exceed 5 Gy to the skin.
• Repeated CT scans: Cumulative dose can become significant if many scans are performed in a short period.
• Radiation therapy errors: Mis‑positioning, equipment malfunction, or planning mistakes can concentrate dose.

Patient‑related risk factors

• Obesity or large body habitus – causes the beam to be concentrated over a smaller skin area.
• Pre‑existing skin conditions (eczema, psoriasis) – reduce the skin’s tolerance.
• Diabetes, peripheral vascular disease, or smoking – impair wound healing.
• Age extremes: children have rapidly dividing skin cells; elderly have thinner epidermis.

Occupational risk factors

• Inadequate shielding (lead aprons, glasses) for staff in cath labs or interventional suites.
• Improper placement of personal dosimeters leading to unrecognized over‑exposure.

Diagnosis

Recognition of radiation‑induced skin injury relies on a combination of clinical history, physical examination, and, when needed, imaging or laboratory tests.

Clinical assessment

• Document the type of X‑ray procedure, total fluence‑time, and estimated skin dose (often recorded by the machine’s dose‑area product, DAP).
• Visual inspection of the skin for erythema, desquamation, ulceration, or fibrosis.
• Assess pain level, functional impairment, and any signs of infection.

Supplemental investigations

• Thermoluminescent dosimetry (TLD) or optically stimulated luminescence (OSL) badges: Provide an objective dose measurement if worn during the procedure.
• Skin biopsy: Rarely required, but can help differentiate radiation dermatitis from other dermatoses.
• Imaging (ultrasound or MRI): Used when deep tissue involvement is suspected.
• Laboratory tests: CBC and CRP if infection is a concern; blood glucose in diabetic patients.

Treatment Options

Management is staged according to severity (Grade 1‑4) and focuses on pain control, promoting healing, and preventing infection.

Grade 1‑2 (Erythema to dry desquamation)

• Topical moisturizers: Aloe‑based or zinc oxide creams applied 2–3 times daily.
• Barrier ointments: Petrolatum or silicone‑based preparations to protect raw skin.
• Analgesia: Acetaminophen or ibuprofen (unless contraindicated).
• Cold compresses: 10‑15 minutes, several times a day, to reduce inflammation.

Grade 3 (Moist desquamation, ulceration)

• Wound care: Non‑adherent dressings (e.g., Mepitel®, hydrocolloid) changed daily.
• Topical antibiotics: Silver sulfadiazine 1 % or mupirocin to prevent infection.
• Systemic antibiotics: If cellulitis develops, culture‑guided therapy (e.g., cefazolin).
• Pain management: Short‑acting opioids (hydrocodone) for breakthrough pain, plus NSAIDs.
• Adjuncts: Hyperbaric oxygen therapy (HBOT) has shown benefit in refractory cases (Cleveland Clinic, 2020).

Grade 4 (Full‑thickness necrosis)

• Surgical debridement: Removal of necrotic tissue by a plastic or reconstructive surgeon.
• Skin grafting or flap coverage: Autologous grafts or myocutaneous flaps for definitive closure.
• Advanced dressings: Silver‑nanoparticle or biologic dressings (e.g., Apligraf®).
• Long‑term physiotherapy: To maintain range of motion and prevent contractures.

Supportive measures for all grades

• Maintain optimal nutrition (protein ≥ 1.2 g/kg/day) to support tissue repair.
• Control blood glucose; target < 180 mg/dL in diabetics.
• Quit smoking; nicotine impairs microcirculation.
• Educate patients about gentle skin handling and avoidance of friction.

Living with X‑Ray Induced Skin Burns

Even after the acute phase resolves, patients may experience chronic changes. Practical tips help minimise discomfort and improve quality of life.

• Skin hygiene: Use mild, fragrance‑free cleansers; pat dry—avoid vigorous rubbing.
• Moisturize daily: Apply thick creams after bathing to prevent xerosis.
• Sun protection: UV exposure exacerbates hyperpigmentation; use SPF 30+ broad‑spectrum sunscreen.
• Clothing: Soft, breathable fabrics (cotton, bamboo) reduce friction; avoid tight elastic bands over the affected area.
• Pain control: Keep a pain diary; discuss persistent pain with your physician—consider neuropathic agents (gabapentin, duloxetine) if burning sensations persist.
• Physical therapy: Gentle range‑of‑motion exercises prevent stiffness, especially after ulceration on joints.
• Psychological support: Chronic skin changes can affect self‑image; counseling or support groups are valuable.
• Follow‑up schedule: Regular visits (every 2–4 weeks initially, then every 3–6 months) to monitor healing and screen for late complications.

Prevention

Preventing radiation burns is a shared responsibility among health‑care providers, patients, and equipment manufacturers.

For health‑care professionals

• Adhere to the ALARA principle – “As Low As Reasonably Achievable.” Use the minimum dose needed for diagnostic quality.
• Employ dose‑reduction technologies: pulsed fluoroscopy, collimation, automatic exposure control.
• Limit fluoroscopy time; pause every 5‑10 minutes to assess skin dose.
• Document cumulative dose in the patient’s chart; consider alternative imaging (MRI, ultrasound) when appropriate.
• Use proper shielding: lead aprons, thyroid collars, leaded glasses.
• Regularly calibrate equipment and perform quality‑assurance checks.

For patients

• Ask the provider about the estimated skin dose before a high‑dose procedure.
• Inform the team of any pre‑existing skin conditions or diabetes.
• Wear protective garments if offered (e.g., lead‑lined gowns).
• Report any new redness, pain, or skin changes within 24 hours after the study.

For occupational safety

• Wear personal dosimeters at waist level and on the thyroid; review badge readings monthly.
• Maintain a safe distance from the X‑ray source; use protective barriers (leaded glass).
• Implement a rotation schedule to limit cumulative exposure for interventional staff.

Complications

If not identified and managed promptly, radiation skin burns can lead to serious sequelae:

• Infection: Bacterial colonisation (Staphylococcus aureus, Pseudomonas) can progress to cellulitis or sepsis.
• Chronic ulceration: Non‑healing wounds may require prolonged wound‑care or surgical reconstruction.
• Fibrosis and contracture: Limiting joint mobility, especially when burns involve the hands, shoulders, or neck.
• Radiation‑induced malignancy: Although rare, high cumulative doses (> 50 Gy) increase the risk of skin cancer (basal cell carcinoma, squamous cell carcinoma).
• Cosmetic disfigurement: Persistent hyper‑ or hypo‑pigmentation impacts self‑esteem.
• Psychological distress: Chronic pain or visible scarring can lead to anxiety or depression.

When to Seek Emergency Care

Early intervention can prevent progression to deeper tissue injury and reduce the likelihood of long‑term complications.

---

Sources: Mayo Clinic, CDC, NIH National Cancer Institute, World Health Organization, Cleveland Clinic, peer‑reviewed journals (Radiotherapy and Oncology, Journal of Burn Care & Research). All links accessed July 2024.

```